Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terlipressin for AKI Prevention in Liver Transplantation
NCT06108362Phase 4Completed
- Sponsor
- Beijing Tsinghua Changgung Hospital
- Start
- Oct 2023
- Primary completion
- Nov 2024
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of terlipressin in acute kidney injury (AKI), sponsored by Beijing Tsinghua Changgung Hospital. Started Oct 2023; status: completed.
02
Drugs
terlipressin
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT06108362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06108362.